| dc.creator |
MUHAFİZ, Ersin; KAFKAS UNIVERSITY |
|
| dc.creator |
ASLAN, Seray; BOZOK UNIVERSITY |
|
| dc.creator |
BAYHAN, Hasan Ali; BOZOK UNIVERSITY |
|
| dc.creator |
ÇÖLGEÇEN, Emine; BOZOK UNIVERSITY |
|
| dc.creator |
GÜRDAL, Canan; Dünya Göz Hospital, Ophthalmology Department |
|
| dc.date |
2021-12-30T00:00:00Z |
|
| dc.date.accessioned |
2022-05-10T10:58:59Z |
|
| dc.date.available |
2022-05-10T10:58:59Z |
|
| dc.identifier |
https://dergipark.org.tr/tr/pub/sdutfd/issue/67913/962200 |
|
| dc.identifier |
10.17343/sdutfd.962200 |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/96228 |
|
| dc.description |
ObjectiveTo evaluate tear functions and Meibomian glands’status in patients with cutaneous rosacea.Material and MethodsRight eyes of 38 patients with cutaneous rosacea(study group) and 30 healthy volunteers (controlgroup) were evaluated. After Ocular Surface DiseaseIndex (OSDI) score was calculated, tear osmolarityand tear break-up time (T-BUT) were measured, andthe Schirmer test was applied respectively. Meibomianglands in the lower and upper eyelids were evaluatedby meibography using the Sirius anterior segmentanalysis system.ResultsNo statistically significant difference was detectedbetween the groups in respect of age and gender(p>0.05). No statistically significant difference wasdetermined between the groups in respect of theOSDI score, tear osmolarity, and Schirmer test values(p>0.05 for all). The T-BUT values of the study groupwere detected to be significantly shorter than thoseof the control group (p |
|
| dc.description |
AmaçCilt rozaseası olan hastalarda gözyaşı fonksiyonlarınıve Meibomian bezlerin durumunu değerlendirmek.Gereç ve YöntemCilt rozaseası olan 38 hasta (çalışma grubu) ile 30sağlıklı gönüllü bireyin (kontrol grubu) sağ gözlerideğerlendirildi. Oküler yüzey hastalık indeksi (OSDI)skoru hesaplandıktan sonra sırasıyla gözyaşı ozmolaritelerive gözyaşı kırılma zamanları (T-BUT) ölçülüpve Schirmer testi yapıldı. Alt ve üst kapaktaki meibomianbezler Sirius ön segment analiz sistemi ile meibografiyapılarak değerlendirildi.BulgularGruplar arasında yaş ve cinsiyet açısından istatistikselolarak anlamlı fark saptanmadı (p>0.05). OSDIskoru, gözyaşı ozmolaritesi ve Schirmer değerleriaçısından gruplar arasında istatistiksel olarak anlamlıfark saptanmadı (tümü için p>0.05). Çalışma grubununT-BUT değerlerinin kontrol grubuna göre anlamlıolarak daha kısa olduğu tespit edildi (p |
|
| dc.format |
application/pdf |
|
| dc.language |
en |
|
| dc.publisher |
Süleyman Demirel Üniversitesi |
|
| dc.publisher |
Süleyman Demirel University |
|
| dc.relation |
https://dergipark.org.tr/tr/download/article-file/1859020 |
|
| dc.source |
Volume: 28, Issue: 4
621-626 |
en-US |
| dc.source |
1300-7416 |
|
| dc.source |
2602-2109 |
|
| dc.source |
SDÜ Tıp Fakültesi Dergisi |
|
| dc.subject |
Cutaneous Rosacea,Tear Functions,Dry Eye,Meibography,Meibomian Glands. |
|
| dc.subject |
Cilt Rozaseası,Gözyaşı Fonksiyonları,Kuru Göz,Meibografi,Meibomian Bezler. |
|
| dc.title |
EVALUATION OF MEIBOMIAN GLANDS IN CUTANEOUS ROSACEA |
en-US |
| dc.title |
CİLT ROZASEASINDA MEİBOMİAN BEZLERİN DEĞERLENDİRİLMESİ |
tr-TR |
| dc.type |
info:eu-repo/semantics/article |
|
| dc.citation |
1. Steinhoff M, Schauber J, Leyden JJ. New insights into rosacea
pathophysiology: a review of recent findings. J Am Acad Dermatol
2013;69:5–26. |
|
| dc.citation |
2. Gallo RL, Granstein RD, Kang S, Mannis M, Steinhoff M, Tan
J, Thiboutot D. Standard classification and pathophysiology of
rosacea: The 2017 update by the National Rosacea Society
Expert Committee. J Am Acad Dermatol 2018;78:148-155. |
|
| dc.citation |
3. Spoendlin J, Voegel JJ, Jick SS, Meier CR. A study on the epidemiology
of rosacea in the U.K. Br J Dermatol 2012;167:598-
605. |
|
| dc.citation |
4. Webster G, Schaller M. Ocular rosacea: a dermatologic perspective.
J Am Acad Dermatol 2013;69:42–43. |
|
| dc.citation |
5. Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis,
and subtype classification. J Am Acad Dermatol
2004;51:327–341. |
|
| dc.citation |
6. Awais M, Anwar MI, Iftikhar R, Iqbal Z, Shehzad N, Akbar B.
Rosacea—the ophthalmic perspective. Cutan Ocul Toxicol
2015;34:161-166. |
|
| dc.citation |
7. Blount BW, Pelletier AL. Rosacea: a common, yet commonly
overlooked, condition. Am Fam Physician 2002;66:435-440. |
|
| dc.citation |
8. Vieira AC, Höfling-Lima AL, Mannis MJ. Ocular rosacea-a review.
Arq Bras Oftalmol 2012;75:363–369. |
|
| dc.citation |
9. Oltz M, Check J. Rosacea and its ocular manifestations. Optometry
2011;82:92–103. |
|
| dc.citation |
10. Wilkin J, Dahl M, Detmar M, Drake L, Liang MH, Odom R,
Powell F. Standard classification of rosacea: Report of the National
Rosacea Society Expert Committee on the classification
and staging of rosacea. J Am Acad Dermatol 2004;50:907-912. |
|
| dc.citation |
11. Ghanem VC, Mehra N, Wong S, Mannis MJ. The prevalence
of ocular signs in acne rosacea: comparing patients from ophthalmology
and dermatology clinics. Cornea 2003;22:230-233. |
|
| dc.citation |
12. Dursun Altınörs D, Asena L. Systemic Diseases and Dry Eye.
MN Oftalmoloji 2016;23:53-59. |
|
| dc.citation |
13. Knop E, Knop N, Millar T, Obata H, Sullivan DA. The international
workshop on meibomian gland dysfunction: report of
the subcommittee on anatomy, physiology, and pathophysiology
of the meibomian gland. Invest Ophthalmol Vis Sci 2011;
52:1938-1978. |
|
| dc.citation |
14. Arita R, Itoh K, Inoue K, Amano S. Noncontact infrared meibography
to document age-related changes of the meibomian glands
in a normal population. Ophthalmology 2008;115:911–915. |
|
| dc.citation |
15. Palamar M, Değirmenci C, Ertam I, Yağci A. Evaluation of dry
eye and meibomian gland dysfunction with meibography in patients
with rosacea. Cornea 2015;34:497–499. |
|
| dc.citation |
16. Holmes AD. Potential role of microorganisms in the pathogenesis
of rosacea. J Am Acad Dermatol 2013;69:1025–1032. |
|
| dc.citation |
17. Müftüoglu İK, Aydın Akova Y. Clinical Findings, Follow-up and
Treatment Results in Patients with Ocular Rosacea. Turk J Ophthalmol
2016;46:1-6. |
|
| dc.citation |
18. Evren Ö, Karci AA, Orhan İ, Artüz F, Tamer U, Sener B, Gürsel
E. Tear Film Function and Lipid Composition of Meibomian
Glands. Turk J Ophthalmol 2006;36:450-456. |
|
| dc.citation |
19. Alvarenga LS, Mannis MJ. Ocular rosacea. Ocul Surf
2005;3:41–58. |
|
| dc.citation |
20. Adil MY, Xiao J, Olafsson J, Chen X, Lagali NS, Ræder S, Utheim
ØA, Dartt DA, Utheim TP. Meibomian Gland Morphology
Is a Sensitive Early Indicator of Meibomian Gland Dysfunction.
Am J Ophthalmol 2019;200:16-25. |
|
| dc.citation |
21. Machalińska A, Zakrzewska A, Markowska A, Safranow K,
Wiszniewska B, Parafiniuk M, Machaliński B. Morphological
and Functional Evaluation of Meibomian Gland Dysfunction in
Rosacea Patients. Curr Eye Res 2016;41:1029-1034. |
|
| dc.citation |
22. Lee WJ, Jung JM, Lee YJ, et al. Histopathological Analysis of
226 Patients With Rosacea According to Rosacea Subtype and
Severity. Am J Dermatopathol 2016; 38: 347-352. |
|
| dc.citation |
23. Liang H, Randon M, Michee S, Tahiri R, Labbe A, Baudouin
C. In vivo confocal microscopy evaluation of ocular and cutaneous
alterations in patients with rosacea. Br J Ophthalmol
2017;101:268-2674. |
|
| dc.citation |
24. Schaller M, Almeida LM, Bewley A, Cribier B, Dlova NC, Kautz
G, Mannis M, Oon HH, Rajagopalan M, Steinhoff M, Thiboutot
D, Troielli P, Webster G, Wu Y, van Zuuren E, Tan J. Rosacea
treatment update: recommendations from the global ROSacea
COnsensus (ROSCO) panel. Br J Dermatol. 2017;176:465-
471. |
|
| dc.citation |
25. Andrade FMX, Picosse FR, Cunha LPD, Valente CM, Bezerra
FM, Miot H, Bagatin E, Freitas D. Ocular surface changes in the
treatment of rosacea: comparison between low-dose oral isotretinoin
and doxycycline. Arq Bras Oftalmol. 2020;83:109-112. |
|
| dc.citation |
26. Holzchuh FG, Hida RY, Moscovici BK, Villa Albers MB, Santo
RM, Kara-José N, Holzchuh R. Clinical treatment of ocular Demodex
folliculorum by systemic ivermectin. Am J Ophthalmol.
2011;151:1030-1034.e1. |
|
| dc.citation |
27. Sobolewska B, Doycheva D, Deuter CM, Schaller M, Zierhut M.
Efficacy of Topical Ivermectin for the Treatment of Cutaneous
and Ocular Rosacea. Ocul Immunol Inflamm. 2020:1-5. Epub
ahead of print. PMID: 32255398. |
|
| dc.citation |
28. Ozek D, Evren Kemer Ö, Artüz F. Assessment of Tear Functions
in Patients with Acne Rosacea without Meibomian Gland
Dysfunction. Ocul Immunol Inflamm 2019;27:632-635. |
|
| dc.citation |
29. Topcu-Yilmaz P, Atakan N, Bozkurt B, Irkec M, Aban D, Mesci L,
Tezcan I. Determination of tear and serum inflammatory cytokines
in patients with rosacea using multiplexbead technology.
Ocul Immunol Inflamm 2013;21:351-359. |
|